Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XENE · as of Jun 8, 2026
Key Statistics
Explore Xenon Pharmaceuticals Inc. Data
xene stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 100.0%
The XENE analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $85.00, representing +63.78% upside from the current price of $51.90.
Competitors & Peers
xene competitorsXENE
AAPG
APGE
CELC
CGON
CNTAStock Performance
Full HistoryAbout Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline in…
what is xenon pharmaceuticals inc. · xene stock overview · xenon pharmaceuticals inc. company profile · who is xenon pharmaceuticals inc. ceo · xene NASDAQ · xenon pharmaceuticals inc. headquarters · xenon pharmaceuticals inc. business segments
About Stock Overview & Key Data
Xenon Pharmaceuticals Inc. (XENE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 5, 2014. As of the latest trading session, XENE stock price is $51.90, with a market capitalization of $4.1B. The stock has returned +64.32% over the past 12 months and +15.31% year-to-date.
According to 22 Wall Street analysts, the consensus rating for Xenon Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $85.00. In fiscal year 2025, Xenon Pharmaceuticals Inc. reported revenue of $7.5M and net income of -$345.9M. For detailed data — including Xenon Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Xenon Pharmaceuticals Inc. (XENE) stock price is $51.90. The stock is traded on NASDAQ under the ticker symbol XENE. The 52-week range is $30.00 – $63.95.